Osmond Resources Limited (ASX:OSM)

Market Cap	88.86M
Revenue (ttm)	188.42K
Net Income (ttm)	-8.36M
Shares Out	97.65M
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,115
Average Volume	295,870
Open	0.9020
Previous Close	0.8850
Day's Range	0.8850 - 0.9100
52-Week Range	0.0690 - 1.0000
Beta	1.39
RSI	62.25
Earnings Date	Sep 16, 2025

About Revance Therapeutics

Osmond Resources Limited operates as an early-stage mineral exploration and development company in Australia. The company primarily explores for gold, nickel, copper, platinum group, and rare earth elements. It holds Yumbarra project comprising EL6417 license located in the western Eyre Peninsula region of South Australia; and Sandford project, which includes EL6958 license located in western Victoria. In addition, the company holds Fowler project that includes EL6603 and EL6604 licenses located in the far west of South Australia; Tallacootra p...

• Industry: Other Precious Metals & Mining
• Sector: Materials
• Founded: 2021
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: OSM

Financial Performance

In 2024, Osmond Resources's revenue was 157,679, an increase of 206.49% compared to the previous year's 51,447. Losses were -1.42 million, 71.5% more than in 2023.